Industry Research Reports
Home > Reports > Chemical & Material > Global Peptide Nucleic Acid (PNA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Peptide Nucleic Acid (PNA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Chemical & Material
Published Date: 2025-04-14
Pages: 102 Pages
Report ld: 4346504
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Peptide Nucleic Acid (PNA) Market Size(US$)
CAGR 2025-2031
14.3%
Market Size,2031
USD 874
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 392 million
Market Forecast in 2031(Value)
US$ 874 million
CAGR
14.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Peptide Nucleic Acid (PNA) market size was US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Peptide nucleic acid (PNA) is a synthetic polymer similar to DNA or RNA. Similar to polypeptides, various purine and pyrimidine bases are connected to the main chain skeleton through methylene carbonyl groups. Since PNA has no negative charge, there is no electrostatic repulsion between it and DNA and RNA, so the stability and specificity of the binding are greatly improved. It is not easily hydrolyzed by DNA enzymes and proteases, and PNA is extremely stable in vivo and in vitro.
Market drivers: With the rapid development of personalized medicine and precision medicine, PNA has shown great potential in the fields of genetic diagnosis, targeted therapy and drug delivery due to its high specificity and stability, which has driven market demand. PNA can be used as an auxiliary material for gene editing tools (such as CRISPR-Cas9) to enhance the efficiency and specificity of gene editing, benefiting from the widespread application of gene editing technology. The application of PNA in molecular diagnostic technologies (such as fluorescence in situ hybridization FISH and PCR) has become an important tool in the field of diagnosis due to its high binding affinity and stability. The policy support and financial investment of governments in precision medicine, gene therapy and biotechnology have created a favorable environment for the PNA market. The continuous improvement of PNA synthesis technology and modification methods has reduced production costs and improved application efficiency, further promoting market development.
Market risks: The synthesis and purification process of PNA is complex and costly, which may limit its large-scale production and commercial application. As a medical and diagnostic tool, PNA needs to pass strict regulatory approval (such as FDA, EMA), and the approval cycle is long and uncertain, which increases the difficulty of market access. The design, synthesis and application of PNA require highly specialized technology, which may limit its popularity in scientific research and clinical practice. PNA faces competition from other nucleic acid analogs (such as siRNA, antisense oligonucleotides) and gene editing technologies, which may affect its market share. PNA technology is relatively new, and market awareness and acceptance are low, which may affect its promotion and application. The supply chain of raw materials and reagents required for PNA production is unstable, which may affect production and delivery. The application of PNA in clinical practice is still in its early stages, and its safety, effectiveness and long-term effects need further verification.
The global Peptide Nucleic Acid (PNA) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- SBS Genetech
- HLB panagene
- LifeTein
- SB-PEPTIDE
- LGC Biosearch Technologies
- Creative Biogene
- Creative Peptides
- BOC Sciences
- PNA BIO INC
- Bio-Synthesis Inc
- Biomers.net
- DESTINA Genomics
- FASMAC
- Allpeptide
- TAHE-PNA
- QiYuebio
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Labeled PNAs
- Unlabeled PNAs
Segment by Application
- Gene Probes
- Drug Development
- Microarrays and Biosensors
- Other
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Peptide Nucleic Acid (PNA) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Unlabeled PNAs in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Drug Development in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Peptide Nucleic Acid (PNA) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Peptide Nucleic Acid (PNA) Product Scope
1.2 Peptide Nucleic Acid (PNA) by Type
1.2.1 Global Peptide Nucleic Acid (PNA) Sales by Type (2020 & 2024 & 2031)
1.2.2 Labeled PNAs
1.2.3 Unlabeled PNAs
1.3 Peptide Nucleic Acid (PNA) by Application
1.3.1 Global Peptide Nucleic Acid (PNA) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Gene Probes
1.3.3 Drug Development
1.3.4 Microarrays and Biosensors
1.3.5 Other
1.4 Global Peptide Nucleic Acid (PNA) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Peptide Nucleic Acid (PNA) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Peptide Nucleic Acid (PNA) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Peptide Nucleic Acid (PNA) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Peptide Nucleic Acid (PNA) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Peptide Nucleic Acid (PNA) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Peptide Nucleic Acid (PNA) Sales Market Share by Region (2020-2025)
2.2.2 Global Peptide Nucleic Acid (PNA) Revenue Market Share by Region (2020-2025)
2.3 Global Peptide Nucleic Acid (PNA) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Peptide Nucleic Acid (PNA) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Peptide Nucleic Acid (PNA) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Peptide Nucleic Acid (PNA) Market Size and Prospective (2020-2031)
2.4.2 Europe Peptide Nucleic Acid (PNA) Market Size and Prospective (2020-2031)
2.4.3 China Peptide Nucleic Acid (PNA) Market Size and Prospective (2020-2031)
2.4.4 Japan Peptide Nucleic Acid (PNA) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Peptide Nucleic Acid (PNA) Historic Market Review by Type (2020-2025)
3.1.1 Global Peptide Nucleic Acid (PNA) Sales by Type (2020-2025)
3.1.2 Global Peptide Nucleic Acid (PNA) Revenue by Type (2020-2025)
3.1.3 Global Peptide Nucleic Acid (PNA) Price by Type (2020-2025)
3.2 Global Peptide Nucleic Acid (PNA) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Peptide Nucleic Acid (PNA) Sales Forecast by Type (2026-2031)
3.2.2 Global Peptide Nucleic Acid (PNA) Revenue Forecast by Type (2026-2031)
3.2.3 Global Peptide Nucleic Acid (PNA) Price Forecast by Type (2026-2031)
3.3 Different Types Peptide Nucleic Acid (PNA) Representative Players
4 Global Market Size by Application
4.1 Global Peptide Nucleic Acid (PNA) Historic Market Review by Application (2020-2025)
4.1.1 Global Peptide Nucleic Acid (PNA) Sales by Application (2020-2025)
4.1.2 Global Peptide Nucleic Acid (PNA) Revenue by Application (2020-2025)
4.1.3 Global Peptide Nucleic Acid (PNA) Price by Application (2020-2025)
4.2 Global Peptide Nucleic Acid (PNA) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Peptide Nucleic Acid (PNA) Sales Forecast by Application (2026-2031)
4.2.2 Global Peptide Nucleic Acid (PNA) Revenue Forecast by Application (2026-2031)
4.2.3 Global Peptide Nucleic Acid (PNA) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Peptide Nucleic Acid (PNA) Application
5 Competition Landscape by Players
5.1 Global Peptide Nucleic Acid (PNA) Sales by Players (2020-2025)
5.2 Global Top Peptide Nucleic Acid (PNA) Players by Revenue (2020-2025)
5.3 Global Peptide Nucleic Acid (PNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Nucleic Acid (PNA) as of 2024)
5.4 Global Peptide Nucleic Acid (PNA) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Peptide Nucleic Acid (PNA), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Peptide Nucleic Acid (PNA), Product Type & Application
5.7 Global Key Manufacturers of Peptide Nucleic Acid (PNA), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Peptide Nucleic Acid (PNA) Sales by Company
6.1.1.1 North America Peptide Nucleic Acid (PNA) Sales by Company (2020-2025)
6.1.1.2 North America Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025)
6.1.2 North America Peptide Nucleic Acid (PNA) Sales Breakdown by Type (2020-2025)
6.1.3 North America Peptide Nucleic Acid (PNA) Sales Breakdown by Application (2020-2025)
6.1.4 North America Peptide Nucleic Acid (PNA) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Peptide Nucleic Acid (PNA) Sales by Company
6.2.1.1 Europe Peptide Nucleic Acid (PNA) Sales by Company (2020-2025)
6.2.1.2 Europe Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025)
6.2.2 Europe Peptide Nucleic Acid (PNA) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Peptide Nucleic Acid (PNA) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Peptide Nucleic Acid (PNA) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Peptide Nucleic Acid (PNA) Sales by Company
6.3.1.1 China Peptide Nucleic Acid (PNA) Sales by Company (2020-2025)
6.3.1.2 China Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025)
6.3.2 China Peptide Nucleic Acid (PNA) Sales Breakdown by Type (2020-2025)
6.3.3 China Peptide Nucleic Acid (PNA) Sales Breakdown by Application (2020-2025)
6.3.4 China Peptide Nucleic Acid (PNA) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Peptide Nucleic Acid (PNA) Sales by Company
6.4.1.1 Japan Peptide Nucleic Acid (PNA) Sales by Company (2020-2025)
6.4.1.2 Japan Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025)
6.4.2 Japan Peptide Nucleic Acid (PNA) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Peptide Nucleic Acid (PNA) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Peptide Nucleic Acid (PNA) Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 SBS Genetech
7.1.1 SBS Genetech Company Information
7.1.2 SBS Genetech Business Overview
7.1.3 SBS Genetech Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 SBS Genetech Peptide Nucleic Acid (PNA) Products Offered
7.1.5 SBS Genetech Recent Development
7.2 HLB panagene
7.2.1 HLB panagene Company Information
7.2.2 HLB panagene Business Overview
7.2.3 HLB panagene Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 HLB panagene Peptide Nucleic Acid (PNA) Products Offered
7.2.5 HLB panagene Recent Development
7.3 LifeTein
7.3.1 LifeTein Company Information
7.3.2 LifeTein Business Overview
7.3.3 LifeTein Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 LifeTein Peptide Nucleic Acid (PNA) Products Offered
7.3.5 LifeTein Recent Development
7.4 SB-PEPTIDE
7.4.1 SB-PEPTIDE Company Information
7.4.2 SB-PEPTIDE Business Overview
7.4.3 SB-PEPTIDE Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 SB-PEPTIDE Peptide Nucleic Acid (PNA) Products Offered
7.4.5 SB-PEPTIDE Recent Development
7.5 LGC Biosearch Technologies
7.5.1 LGC Biosearch Technologies Company Information
7.5.2 LGC Biosearch Technologies Business Overview
7.5.3 LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Products Offered
7.5.5 LGC Biosearch Technologies Recent Development
7.6 Creative Biogene
7.6.1 Creative Biogene Company Information
7.6.2 Creative Biogene Business Overview
7.6.3 Creative Biogene Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Creative Biogene Peptide Nucleic Acid (PNA) Products Offered
7.6.5 Creative Biogene Recent Development
7.7 Creative Peptides
7.7.1 Creative Peptides Company Information
7.7.2 Creative Peptides Business Overview
7.7.3 Creative Peptides Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Creative Peptides Peptide Nucleic Acid (PNA) Products Offered
7.7.5 Creative Peptides Recent Development
7.8 BOC Sciences
7.8.1 BOC Sciences Company Information
7.8.2 BOC Sciences Business Overview
7.8.3 BOC Sciences Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 BOC Sciences Peptide Nucleic Acid (PNA) Products Offered
7.8.5 BOC Sciences Recent Development
7.9 PNA BIO INC
7.9.1 PNA BIO INC Company Information
7.9.2 PNA BIO INC Business Overview
7.9.3 PNA BIO INC Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 PNA BIO INC Peptide Nucleic Acid (PNA) Products Offered
7.9.5 PNA BIO INC Recent Development
7.10 Bio-Synthesis Inc
7.10.1 Bio-Synthesis Inc Company Information
7.10.2 Bio-Synthesis Inc Business Overview
7.10.3 Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Products Offered
7.10.5 Bio-Synthesis Inc Recent Development
7.11 Biomers.net
7.11.1 Biomers.net Company Information
7.11.2 Biomers.net Business Overview
7.11.3 Biomers.net Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Biomers.net Peptide Nucleic Acid (PNA) Products Offered
7.11.5 Biomers.net Recent Development
7.12 DESTINA Genomics
7.12.1 DESTINA Genomics Company Information
7.12.2 DESTINA Genomics Business Overview
7.12.3 DESTINA Genomics Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 DESTINA Genomics Peptide Nucleic Acid (PNA) Products Offered
7.12.5 DESTINA Genomics Recent Development
7.13 FASMAC
7.13.1 FASMAC Company Information
7.13.2 FASMAC Business Overview
7.13.3 FASMAC Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.13.4 FASMAC Peptide Nucleic Acid (PNA) Products Offered
7.13.5 FASMAC Recent Development
7.14 Allpeptide
7.14.1 Allpeptide Company Information
7.14.2 Allpeptide Business Overview
7.14.3 Allpeptide Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Allpeptide Peptide Nucleic Acid (PNA) Products Offered
7.14.5 Allpeptide Recent Development
7.15 TAHE-PNA
7.15.1 TAHE-PNA Company Information
7.15.2 TAHE-PNA Business Overview
7.15.3 TAHE-PNA Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.15.4 TAHE-PNA Peptide Nucleic Acid (PNA) Products Offered
7.15.5 TAHE-PNA Recent Development
7.16 QiYuebio
7.16.1 QiYuebio Company Information
7.16.2 QiYuebio Business Overview
7.16.3 QiYuebio Peptide Nucleic Acid (PNA) Sales, Revenue and Gross Margin (2020-2025)
7.16.4 QiYuebio Peptide Nucleic Acid (PNA) Products Offered
7.16.5 QiYuebio Recent Development
8 Peptide Nucleic Acid (PNA) Manufacturing Cost Analysis
8.1 Peptide Nucleic Acid (PNA) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Peptide Nucleic Acid (PNA)
8.4 Peptide Nucleic Acid (PNA) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Peptide Nucleic Acid (PNA) Distributors List
9.3 Peptide Nucleic Acid (PNA) Customers
10 Peptide Nucleic Acid (PNA) Market Dynamics
10.1 Peptide Nucleic Acid (PNA) Industry Trends
10.2 Peptide Nucleic Acid (PNA) Market Drivers
10.3 Peptide Nucleic Acid (PNA) Market Challenges
10.4 Peptide Nucleic Acid (PNA) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Peptide Nucleic Acid (PNA) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Peptide Nucleic Acid (PNA) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Peptide Nucleic Acid (PNA) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Peptide Nucleic Acid (PNA) Sales (kg) by Region (2020-2025)
Table 5. Global Peptide Nucleic Acid (PNA) Sales Market Share by Region (2020-2025)
Table 6. Global Peptide Nucleic Acid (PNA) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Peptide Nucleic Acid (PNA) Revenue Share by Region (2020-2025)
Table 8. Global Peptide Nucleic Acid (PNA) Sales (kg) Forecast by Region (2026-2031)
Table 9. Global Peptide Nucleic Acid (PNA) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Peptide Nucleic Acid (PNA) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Peptide Nucleic Acid (PNA) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Peptide Nucleic Acid (PNA) Sales by Type (kg) & (2020-2025)
Table 13. Global Peptide Nucleic Acid (PNA) Sales Share by Type (2020-2025)
Table 14. Global Peptide Nucleic Acid (PNA) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Peptide Nucleic Acid (PNA) Price by Type (US$/g) & (2020-2025)
Table 16. Global Peptide Nucleic Acid (PNA) Sales by Type (kg) & (2026-2031)
Table 17. Global Peptide Nucleic Acid (PNA) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Peptide Nucleic Acid (PNA) Price by Type (US$/g) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Peptide Nucleic Acid (PNA) Sales by Application (kg) & (2020-2025)
Table 21. Global Peptide Nucleic Acid (PNA) Sales Share by Application (2020-2025)
Table 22. Global Peptide Nucleic Acid (PNA) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Peptide Nucleic Acid (PNA) Price by Application (US$/g) & (2020-2025)
Table 24. Global Peptide Nucleic Acid (PNA) Sales by Application (kg) & (2026-2031)
Table 25. Global Peptide Nucleic Acid (PNA) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Peptide Nucleic Acid (PNA) Price by Application (US$/g) & (2026-2031)
Table 27. New Sources of Growth in Peptide Nucleic Acid (PNA) Application
Table 28. Global Peptide Nucleic Acid (PNA) Sales by Company (kg) & (2020-2025)
Table 29. Global Peptide Nucleic Acid (PNA) Sales Share by Company (2020-2025)
Table 30. Global Peptide Nucleic Acid (PNA) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Peptide Nucleic Acid (PNA) Revenue Share by Company (2020-2025)
Table 32. Global Peptide Nucleic Acid (PNA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Nucleic Acid (PNA) as of 2024)
Table 33. Global Market Peptide Nucleic Acid (PNA) Average Price by Company (US$/g) & (2020-2025)
Table 34. Global Key Manufacturers of Peptide Nucleic Acid (PNA), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Peptide Nucleic Acid (PNA), Product Type & Application
Table 36. Global Key Manufacturers of Peptide Nucleic Acid (PNA), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Peptide Nucleic Acid (PNA) Sales by Company (2020-2025) & (kg)
Table 39. North America Peptide Nucleic Acid (PNA) Sales Market Share by Company (2020-2025)
Table 40. North America Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Peptide Nucleic Acid (PNA) Revenue Market Share by Company (2020-2025)
Table 42. North America Peptide Nucleic Acid (PNA) Sales by Type (2020-2025) & (kg)
Table 43. North America Peptide Nucleic Acid (PNA) Sales Market Share by Type (2020-2025)
Table 44. North America Peptide Nucleic Acid (PNA) Sales by Application (2020-2025) & (kg)
Table 45. North America Peptide Nucleic Acid (PNA) Sales Market Share by Application (2020-2025)
Table 46. Europe Peptide Nucleic Acid (PNA) Sales by Company (2020-2025) & (kg)
Table 47. Europe Peptide Nucleic Acid (PNA) Sales Market Share by Company (2020-2025)
Table 48. Europe Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Peptide Nucleic Acid (PNA) Revenue Market Share by Company (2020-2025)
Table 50. Europe Peptide Nucleic Acid (PNA) Sales by Type (2020-2025) & (kg)
Table 51. Europe Peptide Nucleic Acid (PNA) Sales Market Share by Type (2020-2025)
Table 52. Europe Peptide Nucleic Acid (PNA) Sales by Application (2020-2025) & (kg)
Table 53. Europe Peptide Nucleic Acid (PNA) Sales Market Share by Application (2020-2025)
Table 54. China Peptide Nucleic Acid (PNA) Sales by Company (2020-2025) & (kg)
Table 55. China Peptide Nucleic Acid (PNA) Sales Market Share by Company (2020-2025)
Table 56. China Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Peptide Nucleic Acid (PNA) Revenue Market Share by Company (2020-2025)
Table 58. China Peptide Nucleic Acid (PNA) Sales by Type (2020-2025) & (kg)
Table 59. China Peptide Nucleic Acid (PNA) Sales Market Share by Type (2020-2025)
Table 60. China Peptide Nucleic Acid (PNA) Sales by Application (2020-2025) & (kg)
Table 61. China Peptide Nucleic Acid (PNA) Sales Market Share by Application (2020-2025)
Table 62. Japan Peptide Nucleic Acid (PNA) Sales by Company (2020-2025) & (kg)
Table 63. Japan Peptide Nucleic Acid (PNA) Sales Market Share by Company (2020-2025)
Table 64. Japan Peptide Nucleic Acid (PNA) Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Peptide Nucleic Acid (PNA) Revenue Market Share by Company (2020-2025)
Table 66. Japan Peptide Nucleic Acid (PNA) Sales by Type (2020-2025) & (kg)
Table 67. Japan Peptide Nucleic Acid (PNA) Sales Market Share by Type (2020-2025)
Table 68. Japan Peptide Nucleic Acid (PNA) Sales by Application (2020-2025) & (kg)
Table 69. Japan Peptide Nucleic Acid (PNA) Sales Market Share by Application (2020-2025)
Table 70. SBS Genetech Company Information
Table 71. SBS Genetech Description and Business Overview
Table 72. SBS Genetech Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. SBS Genetech Peptide Nucleic Acid (PNA) Product
Table 74. SBS Genetech Recent Development
Table 75. HLB panagene Company Information
Table 76. HLB panagene Description and Business Overview
Table 77. HLB panagene Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. HLB panagene Peptide Nucleic Acid (PNA) Product
Table 79. HLB panagene Recent Development
Table 80. LifeTein Company Information
Table 81. LifeTein Description and Business Overview
Table 82. LifeTein Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. LifeTein Peptide Nucleic Acid (PNA) Product
Table 84. LifeTein Recent Development
Table 85. SB-PEPTIDE Company Information
Table 86. SB-PEPTIDE Description and Business Overview
Table 87. SB-PEPTIDE Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. SB-PEPTIDE Peptide Nucleic Acid (PNA) Product
Table 89. SB-PEPTIDE Recent Development
Table 90. LGC Biosearch Technologies Company Information
Table 91. LGC Biosearch Technologies Description and Business Overview
Table 92. LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. LGC Biosearch Technologies Peptide Nucleic Acid (PNA) Product
Table 94. LGC Biosearch Technologies Recent Development
Table 95. Creative Biogene Company Information
Table 96. Creative Biogene Description and Business Overview
Table 97. Creative Biogene Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. Creative Biogene Peptide Nucleic Acid (PNA) Product
Table 99. Creative Biogene Recent Development
Table 100. Creative Peptides Company Information
Table 101. Creative Peptides Description and Business Overview
Table 102. Creative Peptides Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. Creative Peptides Peptide Nucleic Acid (PNA) Product
Table 104. Creative Peptides Recent Development
Table 105. BOC Sciences Company Information
Table 106. BOC Sciences Description and Business Overview
Table 107. BOC Sciences Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 108. BOC Sciences Peptide Nucleic Acid (PNA) Product
Table 109. BOC Sciences Recent Development
Table 110. PNA BIO INC Company Information
Table 111. PNA BIO INC Description and Business Overview
Table 112. PNA BIO INC Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 113. PNA BIO INC Peptide Nucleic Acid (PNA) Product
Table 114. PNA BIO INC Recent Development
Table 115. Bio-Synthesis Inc Company Information
Table 116. Bio-Synthesis Inc Description and Business Overview
Table 117. Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 118. Bio-Synthesis Inc Peptide Nucleic Acid (PNA) Product
Table 119. Bio-Synthesis Inc Recent Development
Table 120. Biomers.net Company Information
Table 121. Biomers.net Description and Business Overview
Table 122. Biomers.net Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 123. Biomers.net Peptide Nucleic Acid (PNA) Product
Table 124. Biomers.net Recent Development
Table 125. DESTINA Genomics Company Information
Table 126. DESTINA Genomics Description and Business Overview
Table 127. DESTINA Genomics Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 128. DESTINA Genomics Peptide Nucleic Acid (PNA) Product
Table 129. DESTINA Genomics Recent Development
Table 130. FASMAC Company Information
Table 131. FASMAC Description and Business Overview
Table 132. FASMAC Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 133. FASMAC Peptide Nucleic Acid (PNA) Product
Table 134. FASMAC Recent Development
Table 135. Allpeptide Company Information
Table 136. Allpeptide Description and Business Overview
Table 137. Allpeptide Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 138. Allpeptide Peptide Nucleic Acid (PNA) Product
Table 139. Allpeptide Recent Development
Table 140. TAHE-PNA Company Information
Table 141. TAHE-PNA Description and Business Overview
Table 142. TAHE-PNA Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 143. TAHE-PNA Peptide Nucleic Acid (PNA) Product
Table 144. TAHE-PNA Recent Development
Table 145. QiYuebio Company Information
Table 146. QiYuebio Description and Business Overview
Table 147. QiYuebio Peptide Nucleic Acid (PNA) Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 148. QiYuebio Peptide Nucleic Acid (PNA) Product
Table 149. QiYuebio Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Peptide Nucleic Acid (PNA) Distributors List
Table 153. Peptide Nucleic Acid (PNA) Customers List
Table 154. Peptide Nucleic Acid (PNA) Market Trends
Table 155. Peptide Nucleic Acid (PNA) Market Drivers
Table 156. Peptide Nucleic Acid (PNA) Market Challenges
Table 157. Peptide Nucleic Acid (PNA) Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Nucleic Acid (PNA) Product Picture
Figure 2. Global Peptide Nucleic Acid (PNA) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Peptide Nucleic Acid (PNA) Sales Market Share by Type in 2024 & 2031
Figure 4. Labeled PNAs Product Picture
Figure 5. Unlabeled PNAs Product Picture
Figure 6. Global Peptide Nucleic Acid (PNA) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Peptide Nucleic Acid (PNA) Sales Market Share by Application in 2024 & 2031
Figure 8. Gene Probes Examples
Figure 9. Drug Development Examples
Figure 10. Microarrays and Biosensors Examples
Figure 11. Other Examples
Figure 12. Global Peptide Nucleic Acid (PNA) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide Nucleic Acid (PNA) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Peptide Nucleic Acid (PNA) Sales (kg) Growth Rate (2020-2031)
Figure 15. Global Peptide Nucleic Acid (PNA) Price Trends Growth Rate (2020-2031) & (US$/g)
Figure 16. Peptide Nucleic Acid (PNA) Report Years Considered
Figure 17. Global Market Peptide Nucleic Acid (PNA) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Peptide Nucleic Acid (PNA) Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Peptide Nucleic Acid (PNA) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Peptide Nucleic Acid (PNA) Sales (kg) Growth Rate (2020-2031)
Figure 21. Europe Peptide Nucleic Acid (PNA) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Peptide Nucleic Acid (PNA) Sales (kg) Growth Rate (2020-2031)
Figure 23. China Peptide Nucleic Acid (PNA) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Peptide Nucleic Acid (PNA) Sales (kg) Growth Rate (2020-2031)
Figure 25. Japan Peptide Nucleic Acid (PNA) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Peptide Nucleic Acid (PNA) Sales (kg) Growth Rate (2020-2031)
Figure 27. Global Peptide Nucleic Acid (PNA) Revenue Share by Type (2020-2025)
Figure 28. Global Peptide Nucleic Acid (PNA) Sales Share by Type (2026-2031)
Figure 29. Global Peptide Nucleic Acid (PNA) Revenue Share by Type (2026-2031)
Figure 30. Global Peptide Nucleic Acid (PNA) Revenue Share by Application (2020-2025)
Figure 31. Global Peptide Nucleic Acid (PNA) Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Peptide Nucleic Acid (PNA) Sales Share by Application (2026-2031)
Figure 33. Global Peptide Nucleic Acid (PNA) Revenue Share by Application (2026-2031)
Figure 34. Global Peptide Nucleic Acid (PNA) Sales Share by Company (2024)
Figure 35. Global Peptide Nucleic Acid (PNA) Revenue Share by Company (2024)
Figure 36. Global 5 Largest Peptide Nucleic Acid (PNA) Players Market Share by Revenue in Peptide Nucleic Acid (PNA): 2020 & 2024
Figure 37. Peptide Nucleic Acid (PNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Peptide Nucleic Acid (PNA)
Figure 39. Manufacturing Process Analysis of Peptide Nucleic Acid (PNA)
Figure 40. Peptide Nucleic Acid (PNA) Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Peptide Nucleic Acid (PNA) in 2025?
The global market size of Peptide Nucleic Acid (PNA) in 2025 was 392 Million USD.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Peptide Nucleic Acid (PNA) market size from 2025 to 2031?
Which companies rank high in the global Peptide Nucleic Acid (PNA) market?
What was the global market size of Peptide Nucleic Acid (PNA) in 2031?
Related Reports
Global Peptide Nucleic Acid (PNA) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Peptide Nucleic Acid (PNA) market size was US$ 392 million in 2025 and is forecast to reach a readjusted size of US$ 987 million by 2032 with a CAGR of 14.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 104
USD 4250.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 987 million by 2032, at a CAGR of 14.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 180
USD 4900.00
(Single User License)
Peptide Nucleic Acid (PNA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 392 million in 2025 and is projected to reach US$ 987 million, growing at a CAGR of 14.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 142
USD 3950.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Market Research Report 2026
The global Peptide Nucleic Acid (PNA) market was valued at US$ 392 million in 2025 and is anticipated to reach US$ 987 million by 2032, at a CAGR of 14.3% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 151
USD 2900.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 364 million in 2024 to US$ 874 million by 2031, at a CAGR of 14.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Market Insights, Forecast to 2031
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 874 million by 2031, at a Compound Annual Growth Rate (CAGR) of 14.3% during the forecast period.
Published Date: 2025-04-14
Pages: 179
USD 4900.00
(Single User License)
Peptide Nucleic Acid (PNA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 141
USD 3950.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Market Research Report 2025
The global market for Peptide Nucleic Acid (PNA) was valued at US$ 364 million in the year 2024 and is projected to reach a revised size of US$ 874 million by 2031, growing at a CAGR of 14.3% during the forecast period.
Published Date: 2025-04-14
Pages: 106
USD 2900.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Market Research Report 2024
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published Date: 2024-10-25
Pages: 113
USD 2900.00
(Single User License)
Global and United States Peptide Nucleic Acid (PNA) Market Report & Forecast 2024-2030
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published Date: 2024-10-25
Pages: 146
USD 4350.00
(Single User License)
Global Peptide Nucleic Acid (PNA) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Peptide Nucleic Acid (PNA) market size was US$ 392 million in 2025 and is forecast to reach a readjusted size of US$ 987 million by 2032 with a CAGR of 14.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 104
USD 4250.00 (Single User License)Global Peptide Nucleic Acid (PNA) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 987 million by 2032, at a CAGR of 14.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 180
USD 4900.00 (Single User License)Peptide Nucleic Acid (PNA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 392 million in 2025 and is projected to reach US$ 987 million, growing at a CAGR of 14.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 142
USD 3950.00 (Single User License)Global Peptide Nucleic Acid (PNA) Market Research Report 2026
The global Peptide Nucleic Acid (PNA) market was valued at US$ 392 million in 2025 and is anticipated to reach US$ 987 million by 2032, at a CAGR of 14.3% from 2026 to 2032.
Published: 2026-03-05
Pages: 151
USD 2900.00 (Single User License)Global Peptide Nucleic Acid (PNA) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 364 million in 2024 to US$ 874 million by 2031, at a CAGR of 14.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
USD 4900.00 (Single User License)Global Peptide Nucleic Acid (PNA) Market Insights, Forecast to 2031
The global Peptide Nucleic Acid (PNA) market is projected to grow from US$ 392 million in 2025 to US$ 874 million by 2031, at a Compound Annual Growth Rate (CAGR) of 14.3% during the forecast period.
Published: 2025-04-14
Pages: 179
USD 4900.00 (Single User License)Peptide Nucleic Acid (PNA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide Nucleic Acid (PNA) was estimated to be worth US$ 364 million in 2024 and is forecast to a readjusted size of US$ 874 million by 2031 with a CAGR of 14.3% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 141
USD 3950.00 (Single User License)Global Peptide Nucleic Acid (PNA) Market Research Report 2025
The global market for Peptide Nucleic Acid (PNA) was valued at US$ 364 million in the year 2024 and is projected to reach a revised size of US$ 874 million by 2031, growing at a CAGR of 14.3% during the forecast period.
Published: 2025-04-14
Pages: 106
USD 2900.00 (Single User License)Global Peptide Nucleic Acid (PNA) Market Research Report 2024
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published: 2024-10-25
Pages: 113
USD 2900.00 (Single User License)Global and United States Peptide Nucleic Acid (PNA) Market Report & Forecast 2024-2030
Peptide nucleic acid (PNA) is a synthetic molecule that is similar to DNA and RNA in its structure.The binding affinity and selectivity of PNA towards DNA, RNA is higher than for the analogous DNA duplexes due to the neutral character of PNA. PNA has better discriminating power with a more effective single base mismatch discrimination than DNA.PNA oligomers are resistant to enzymatic degradation by proteases and nucleases, which extends their lifetime for applications in vitro and in vivo. PNAs are also stable over a wide pH range and quite stable under high temperature.
Published: 2024-10-25
Pages: 146
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now